Home > Insider Trading > Filing (0001209191-17-034923)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
917520	Integra Lifesciences Holdings Corp	IART	Laboratory Analytical Instruments (3826)	510317849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187574	Stuart Essig	311 C Enterprise Drive Plainsboro NJ 08536		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-05-22	44,571	$17.45	1,973,335	No	4	M	Direct
Common Stock	Disposition	2017-05-22	44,571	$48.01	1,928,764	No	4	S	Direct
Common Stock	Acquisiton	2017-05-23	68,780	$17.45	1,997,544	No	4	M	Direct
Common Stock	Acquisiton	2017-05-23	95,429	$17.45	2,092,973	No	4	M	Direct
Common Stock	Disposition	2017-05-23	95,429	$48.01	1,997,544	No	4	S	Direct
Common Stock	Acquisiton	2017-05-23	4,587	$0.00	2,002,131	No	4	A	Direct
Common Stock	Acquisiton	2017-05-23	1,564	$0.00	2,003,695	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	A	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2017-05-22	44,571	$0.00	44,571	$17.45
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2017-05-23	68,780	$0.00	68,780	$17.45
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2017-05-23	95,429	$0.00	95,429	$17.45

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
372,989	2017-12-18	No	4	M	Direct
304,209	2017-12-18	No	4	M	Direct
208,780	2017-12-18	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $48 to $48.10.
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $47.90 to $48.14.
25% of the option grant vested on 12/18/2008 (the first anniversary of the grant date of 12/18/2007), and the remaining 75% vested monthly thereafter over 36 months.
This stock option was previously reported as covering 208,780 shares of common stock at an exercise price of $34.90 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.